Medical Condition News

RSS

Encouraging results from ReShape Duo Phase 1 study for treatment of obesity

ReShape Medical, Inc. today announces results of its U.S. Phase 1 investigational clinical study. This feasibility study of thirty subjects assessed the safety and effectiveness of the ReShape Duo in conjunction with lifestyle modification in patients with a body mass index of 30-40.

17 Jun 2011

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Celgene International Sarl today announced a collaboration to conduct an international randomized study to evaluate the therapeutic potential of the REVLIMID/rituximab combination regimen (R2) in patients with newly diagnosed follicular lymphoma.

17 Jun 2011

Careful, well-designed studies needed for evaluating patients with MS: SIRF panel

Evaluating patients with multiple sclerosis who have narrowed jugular and azygos veins-and the value of widening those veins with angioplasty-warrants careful, well-designed research, noted members of a Society of Interventional Radiology Foundation's Research Consensus Panel.

17 Jun 2011

Health care in the U.S. must focus primarily on disease prevention: Surgeon General

U.S. Surgeon General Regina Benjamin said Monday that health care in the United States must shift its primary focus to disease prevention rather than the treatment of illness.

17 Jun 2011

Precisely mapped allosteric binding site will facilitate design of drugs with minimal side effects

Structural biologists at Cold Spring Harbor Laboratory (CSHL) have obtained a precise molecular map of the binding site for an allosteric inhibitor in a subtype of the NMDA (N-methyl-D-aspartate) receptor, which is commonly expressed in brain cells.

17 Jun 2011

Scientists reveal complex protein mechanism that regulates genes linked with cancer

Scientists at Memorial Sloan-Kettering Cancer Center in New York and at IRB Barcelona reveal the mechanism of action of a protein that is essential for life and is associated with disease.

17 Jun 2011

VIVUS Avanafil phase 3 trial on erectile dysfunction meets primary endpoints

VIVUS, Inc. today announced that the positive results from REVIVE-RP, a phase 3 clinical trial evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED),will be presented this afternoon at the 2011 Cancer Survivorship and Sexual Health Symposium in Washington D.C.

17 Jun 2011

Loyola employee donates kidney to complete stranger, saves her own life

When Dorothy Jambrosek, 47, decided to donate a kidney to a stranger, she didn't realize that her goodwill would save her own life. After undergoing a series of tests required to give a kidney, doctors discovered that Jambrosek had precancerous lesions in her breast that could become cancerous.

17 Jun 2011

Allos Therapeutics reports results from FOLOTYN pivotal trial against peripheral T-cell lymphoma

Allos Therapeutics, Inc. today reported results from a retrospective analysis of data from the Company's pivotal PROPEL trial which suggested that treatment with single-agent FOLOTYN may result in increased response rates and progression-free survival relative to the immediate prior line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma.

17 Jun 2011

'Ultrawideband' technology for real-time health diagnosis

New research by electrical engineers at Oregon State University has confirmed that an electronic technology called "ultrawideband" could hold part of the solution to an ambitious goal in the future of medicine - health monitoring with sophisticated "body-area networks."

17 Jun 2011

Innovative adult stem cell approach could help eliminate obesity

Innovative adult stem cell research by scientists at The University of Texas Health Science Center at Houston could aid efforts to apply the brakes to stem cells that produce the type of fat ringing the waists of millions. Research appeared today online ahead of the print issue of Cell Stem Cell.

17 Jun 2011

Fast-acting antidepressant effect of ketamine

UT Southwestern Medical Center scientists are shedding new light on why the anesthetic drug ketamine produces a fast-acting antidepressant response in patients with treatment-resistant depression.

17 Jun 2011

Medical societies urge diabetes patients to remain on their prescribed medications

Diabetes leaders today are responding to the announcement made by the U.S. Food and Drug Administration (FDA) yesterday that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.

17 Jun 2011

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Celgene International Sàrl announced that clinical data from two studies evaluating the use of REVLIMID® (lenalidomide) with standard R-CHOP chemotherapy in patients with untreated diffuse large B cell (DLBCL) or grade 3 follicular lymphoma were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

17 Jun 2011

Nuvilex describes advantages of cell encapsulation technology for multiple cancer therapies

Nuvilex, Inc. described today potential advantages of cell encapsulation technology for use in cancer therapies when more than one cancer-fighting drug is used.

17 Jun 2011

Pearl advances PT003 dual combination drug candidate into Phase 2 studies for treatment of COPD

Pearl Therapeutics Inc. today announced the advancement of its dual combination product candidate, PT003 and its individual components, PT001 and PT005 into a series of planned Phase 2 studies in patients with moderate-to-severe COPD.

17 Jun 2011

Obese, overweight and still healthy

It's become an axiom of health that overweight and obese people are not as healthy as their normal weight counterparts. In fact, obesity has been targeted as one of the country's most serious public health problems, with predictions of widespread heart disease, diabetes and cancer among the growing number of Americans who are overweight.

17 Jun 2011

AHRQ finds more rural emergency department visits among low-income adults

Low-income adults ages 18 to 64 accounted for 56 percent of the 8 million visits made to rural hospital emergency departments in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

17 Jun 2011

Snack-based diet can increase risk of obesity

A high-fat diet can be bad for your health. However, a snack-based "cafeteria"-style diet of highly palatable, energy-dense foods is even worse, according to new research.

17 Jun 2011

CTI announces positive results from Phase I-II pixantrone combination study against INHL

Cell Therapeutics, Inc. announced the publication of results posted in the online journal of Cancer of a Phase I-II study that evaluated the safety and efficacy of pixantrone when used in combination with fludarabine, dexamethasone and rituximab replacing mitoxantrone in the standard FND-R regimen with FPD-R among 28 patients with relapsed or refractory indolent non-Hodgkin's lymphoma.

17 Jun 2011

Medical Condition News

Encouraging results from ReShape Duo Phase 1 study for treatment of obesity

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Careful, well-designed studies needed for evaluating patients with MS: SIRF panel

Health care in the U.S. must focus primarily on disease prevention: Surgeon General

Precisely mapped allosteric binding site will facilitate design of drugs with minimal side effects

Scientists reveal complex protein mechanism that regulates genes linked with cancer

VIVUS Avanafil phase 3 trial on erectile dysfunction meets primary endpoints

Loyola employee donates kidney to complete stranger, saves her own life

Allos Therapeutics reports results from FOLOTYN pivotal trial against peripheral T-cell lymphoma

'Ultrawideband' technology for real-time health diagnosis

Innovative adult stem cell approach could help eliminate obesity

Fast-acting antidepressant effect of ketamine

Medical societies urge diabetes patients to remain on their prescribed medications

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Nuvilex describes advantages of cell encapsulation technology for multiple cancer therapies

Pearl advances PT003 dual combination drug candidate into Phase 2 studies for treatment of COPD

Obese, overweight and still healthy

AHRQ finds more rural emergency department visits among low-income adults

Snack-based diet can increase risk of obesity

CTI announces positive results from Phase I-II pixantrone combination study against INHL

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News